Mentioned the reagent/staffing issue in my piece on Friday, but here’s a contact explaining the current UK lab capacity issue.

‘My understanding is the [pillar 2] labs were employing students who are now going back to uni. An issue appears to be that the public labs have... 1/

the workforce, could expand capacity but are limited by reagent supply; the private labs have capacity and plenty of reagent but limited by staffing... 2/

...it’s because these have been set up as separate siloed programmes instead of a whole asset based integrated system and network.’ 3/

They say that’s the underlying issue; not too many people going for tests.

Although demand has also increased - but it isn’t the root cause of what’s going on here, from what they and others are saying.

I’m going to make a brew